This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 20, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will release results for the second quarter of 2011, on
Thursday, August 4, 2011, before the market opens. A full text copy of the release will be disseminated at that time.
Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at
10:00 AM ET on
Thursday, August 4, 2011. Also participating on the call will be
James Kelly, Senior Vice President and Chief Financial Officer. To participate in the conference call, dial the appropriate number below shortly before the
10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.
The teleconference dial-in numbers are as follows:
Domestic callers 1-866-314-5232
International callers 1-617-213-8052
Participant Passcode 16117516
The conference call will be broadcast simultaneously and archived on the Company's website,
www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on
Thursday, August 4, 2011, beginning at
1:00 PM ET and will be accessible until
Thursday, August 11, 2011, at
5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 57140859.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit
Company Contact:Cristina MurphyCommunications ManagerVanda Pharmaceuticals Inc.(240) 599-4500
SOURCE Vanda Pharmaceuticals Inc.